Table 3.
List of Expected Serious Adverse Events
| Serious adverse event | Estimated incidence [17] |
|---|---|
| Death | 20% |
| Necrotising enterocolitis (diagnostic radiological/surgical changes) | 15% |
| Intracranial abnormality on cranial ultrasound scan | 15% |
| (paraenchymal haemorrhage or focal white matter injury) | |
| Ventilator dependency (28 days) and/or oxygen dependency (36 weeks CGA) | 65% |
| Patent ductus arteriosus medical or surgical management | 25% |
| Retinal surgery for retinopathy of prematurity | 5% |
| Pulmonary haemorrhage | 5% |
| Infection ( positive blood culture with clinical signs) | 65% |
| Persistent derangement of liver function tests (36 wks CGA) | 10% |
| Serious extravasation injury (permanent scarring and/or/joint deformity) | <5% |
CGA: corrected gestational age